57 companies

Avant Brands

Market Cap: CA$11.2m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

AVNT

CA$1.07

7D

-7.0%

1Y

-60.4%

Crescita Therapeutics

Market Cap: CA$10.1m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

CTX

CA$0.53

7D

-5.4%

1Y

26.2%

Quest PharmaTech

Market Cap: CA$9.3m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

QPT

CA$0.055

7D

83.3%

1Y

57.1%

Australis Capital

Market Cap: CA$8.7m

Operates as a cannabis company.

AUSA

CA$0.025

7D

0%

1Y

-82.8%

Medicure

Market Cap: CA$7.6m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

MPH

CA$0.73

7D

-7.6%

1Y

-32.4%

Cytophage Technologies

Market Cap: CA$7.3m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

CYTO

CA$0.14

7D

0%

1Y

-71.0%

Herbal Dispatch

Market Cap: CA$5.3m

Owns and operates cannabis e-commerce platforms in Canada and the United States.

HERB

CA$0.065

7D

8.3%

1Y

30.0%

Delivra Health Brands

Market Cap: CA$5.3m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

DHB

CA$0.17

7D

-10.5%

1Y

-51.4%

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

CALI.X

CA$0.005

7D

0%

1Y

n/a

Ayurcann Holdings

Market Cap: CA$4.9m

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

AYUR

CA$0.025

7D

-16.7%

1Y

-37.5%

XORTX Therapeutics

Market Cap: CA$4.5m

A late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection.

XRTX

CA$1.20

7D

-6.3%

1Y

-74.0%

Awakn Life Sciences

Market Cap: CA$4.0m

A biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe.

AWKN

CA$0.095

7D

0%

1Y

-26.9%

1933 Industries

Market Cap: CA$2.5m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

TGIF

CA$0.005

7D

0%

1Y

-75.0%

Biocure Technology

Market Cap: CA$2.4m

Together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab.

CURE.X

CA$0.025

7D

0%

1Y

n/a

Captor Capital

Market Cap: CA$2.1m

Engages in the retail sale of cannabis products in the United States.

CPTR

CA$0.59

7D

-4.8%

1Y

-28.5%

West Island Brands

Market Cap: CA$2.0m

Engages in the medical marijuana business.

WIB

CA$0.13

7D

0%

1Y

4.0%

Adastra Holdings

Market Cap: CA$1.9m

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.

XTRX

CA$0.34

7D

0%

1Y

-86.0%

RAMM Pharma

Market Cap: CA$1.8m

Through its subsidiaries, operates pharmaceutical and medical product business in Uruguay, Italy, and Poland.

RAMM

CA$0.015

7D

0%

1Y

-75.0%

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

STRC.X

CA$0.005

7D

0%

1Y

0%

Lowell Farms

Market Cap: CA$544.5k

Engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California.

LOWL

CA$0.03

7D

0%

1Y

-78.6%

Many Bright Ideas Technologies

Market Cap: CA$345.2k

Does not have significant operations.

MBI.H

CA$0.02

7D

0%

1Y

-78.9%

Page 2 of 2